Abstracts - faqs.org

Abstracts

Psychology and mental health

Search abstracts:
Abstracts » Psychology and mental health

Low dose desipramine treatment of cocaine-related panic attacks

Article Abstract:

It has recently been reported that cocaine use can trigger panic attacks, and that these attacks may continue even after cocaine is no longer used. During a panic attack, the person feels intense anxiety and fear, typically accompanied by physical symptoms such as nausea and sweating. Surprisingly, when patients with cocaine-related panic disorder have been treated with medications that normally reduce anxiety (tricyclic antidepressants), they have experienced heightened anxiety. The dosage of such medications may be critical, however; the authors have successfully treated such patients with ultra-low-dose tricyclic antidepressants. In this article, they describe 13 patients who had panic disorder that began during or soon after their cocaine use (12 weeks on average); when treatment began all the patients had stopped using cocaine because of the panic attacks. The patients were treated with ultra-low initial doses of the tricyclic antidepressant desipramine (2.5 to 10 milligrams per day). The dosage was gradually increased to an average of 25 milligrams per day. Two patients withdrew from the program after starting treatment, but the 11 remaining patients responded well to the medication after they were able to tolerate an increase in anxiety as they began treatment. This initial increase in anxiety was managed with relaxation techniques and, if necessary, a reduction of the desipramine dose. All 11 patients eventually experienced great improvement in their panic symptoms, and for nine (82 percent), the attacks resolved completely. The authors acknowledge that behavioral interventions, such as relaxation techniques, may have contributed to the patients' improvement. The possible neurological mechanisms that could explain the relationships among cocaine, panic attacks, and tricyclic antidepressants are discussed. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Pasnau, Robert O., Bystritsky, Alexander, Ackerman, Deborah L.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Nervous and Mental Disease
Subject: Psychology and mental health
ISSN: 0022-3018
Year: 1991
Health aspects, Physiological aspects, Drug therapy, Cocaine abuse, Panic disorders, Panic disorder, Cocaine, Antidepressants, Tricyclic, Tricyclic antidepressants, Desipramine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Psychiatric syndromes linked to reproductive function in women: a review of current knowledge

Article Abstract:

Four psychiatric disorders involving women's reproductive function are postpartum depression, premenstrual syndrome (PMS), post-hysterectomy depression, and involutional melancholia (menopausal depression). The understanding of psychiatric syndromes that are linked to women's reproductive function has been clouded by myths, incorrect assumptions and research data based on unscientific methodology. This article reviews the results of newer, better studies in order to update present knowledge of each syndrome. Postpartum depression ranges in severity from brief emotional lability and tearfulness to severe psychotic depression. Psychiatric hospital admissions are substantially higher for women in the first three postpartum months and slightly higher for up to two years after uncomplicated childbirth. PMS has received much attention, but is poorly understood because it is difficult to study objectively. Wide variation in symptoms, their severity and their duration has caused controversy over the proper definition of PMS. Treatments are as yet experimental, but include exercise, reduction of salt and caffeine intake and, if necessary, medications for specific symptoms. The existence of post-hysterectomy depression is no longer supported by research data; there is minimal evidence that hysterectomy results in an elevated rate of depression. Experts now also believe that menopausal depression is a mythical condition.

Author: Gitlin, Michael J., Pasnau, Robert O.
Publisher: American Psychiatric Association
Publication Name: American Journal of Psychiatry
Subject: Psychology and mental health
ISSN: 0002-953X
Year: 1989
Research, Menopause, Hysterectomy, Premenstrual syndrome, Women patients, Postpartum psychiatric disorders

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A psychiatrist's reaction to a patient's suicide

Article Abstract:

The response of a psychiatrist to a patient's suicide is discussed in a clinical case conference. The incident occurred relatively early in the psychiatrist's career, which may have made it more difficult.

Author: Gitlin, Michael J.
Publisher: American Psychiatric Association
Publication Name: American Journal of Psychiatry
Subject: Psychology and mental health
ISSN: 0002-953X
Year: 1999
Statistical Data Included, Case studies, Suicide, Psychiatrists, Therapist-patient relations, Psychotherapist and patient

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Psychological aspects
Similar abstracts:
  • Abstracts: Practice guideline for the treatment of patients with panic disorder. Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids
  • Abstracts: Ipsapirone in the treatment of bulimia nervosa: an open pilot study. Influence of shape and weight on self-evaluation in bulimia nervosa
  • Abstracts: HIV seroprevalence among patients admitted to two psychiatric hospitals. Living and dying with HIV/AIDS: a psychosocial perspective
  • Abstracts: The case for evidence-based psychotherapy treatment guidelines. Psychotherapy of sexual dysfunction
  • Abstracts: On developing self-concepts: a controlled study of children and adolescents with autism. Children's language learning: An interactionist perspective
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.